[1] Olsen JV,Mann M.Status of large-scale analysis of post-translational modifications by mass spectrometry[J].Mol Cell Proteomics,2013,12(12):3444-3452. [1] Reily C,Stewart TJ,Renfrow MB,et al.Glycosylation in health and disease[J].Nat Rev Nephrol,2019,15(6):346-366. [2] Kiermaier E,Moussion C,Veldkamp CT,et al.Polysialylation controls dendritic cell trafficking by regulating chemokine recognition[J].Science,2016,351(6269):186-190. [3] Schjoldager KT,Narimatsu Y,Joshi HJ,et al.Global view of human protein glycosylation pathways and functions[J].Nat Rev Mol Cell Biol,2020,21(12):729-749. [4] Campos D,Freitas D,Gomes J,et al.Probing the O-glycoproteome of gastric cancer cell lines for biomarker discovery[J].Mol Cell Proteomics,2015,14(6):1616-1629. [5] Boix CP,Lopez-Font I,Cuchillo-Ibañez I,et al.Amyloid precursor protein glycosylation is altered in the brain of patients with Alzheimer's disease[J].Alzheimers Res Ther,2020,12(1):96. [6] Kippe JM,Mueller TM,Haroutunian V,et al.Abnormal N-acetylglucosaminyltransferase expression in prefrontal cortexin schizophrenia[J].Schizophr Res,2015,166(1-3):219-224. [7] Veillon L,Fakih C,Abou-El-Hassan H,et al.Glycosylation changes in brain cancer[J].ACS Chem Neurosci,2018,9(1):51-72. [8] Freeze HH,Eklund EA,Ng BG,et al.Neurology of inherited glycosylation disorders[J].Lancet Neurol,2012,11(5): 453-466. [9] Verheijen J,Tahata S,Kozicz T,et al.Therapeutic approaches in congenital disorders of glycosylation (CDG) involving N-linked glycosylation: An update[J].Genet Med,2020,22(2):268-279. [10] Coman D,McGill J,MacDonald R,et al.Congenital disorder of glycosylation type 1a: Three siblings with a mild neurological phenotype[J].J Clin Neurosci,2017,14(7):668-672. [11] 王晓龙,王秀然,卢天成.蛋白质糖基化修饰的研究进展[J].基因组学与应用生物学,2017,36(10):4380-4384. [12] Schwarz F,Aebi M.Mechanisms and principles of N-linked protein glycosylation[J].Curr Opin Struct Biol,2011,21(5):576-582. [13] Wani WY,Chatham JC,Darley-Usmar V,et al.O-GlcNAcylation and neurodegeneration[J].Brain Res Bull,2017,133:80-87. [14] van Tol W,Wessels H,Lefeber DJ.O-glycosylation disorders pave the road for understanding the complex human O-glycosylation machinery[J].Curr Opin Struct Biol,2019,56:107-118. [15] Iqbal S,Ghanimi Fard M,Everest-Dass A,et al.Understanding cellular glycan surfaces in the central nervous system[J].Biochem Soc Trans,2019,47(1):89-100. [16] ScottH,Panin VM.The role of protein N-glycosylation in neural transmission[J].Glycobiology,2014,24(5):407-417. [17] Congdon EE,Sigurdsson EM.Tau-targeting therapies for Alzheimer disease[J].Nat Rev Neurol,2018,14(7):399-415. [18] Taylor EW, WangK,Nelson AR,et al.O-GlcNAcylation of AMPA receptor GluA2 is associated with a novel form of long-term depression at hippocampal synapses[J].J Neurosci,2014,34(1):10-21. [19] Hu H,Li J,Gagen CS,et al.Conditional knockout of protein O-mannosyl transferase 2 reveals tissue-specific roles of O-mannosyl glycosylation in brain development[J].J Comp Neurol 2011,519(7):1320-1337. [20] Chang IJ, He M, LamCT.Congenital disorders of glycosylation[J].Ann Transl Med,2018,6(24):477. [21] Gámez A,Serrano M,Gallego D,et al.New and potential strategies for the treatment of PMM2-CDG[J].Biochim Biophys Acta Gen Subj,2020,1864(11):129686. [22] Barone R,Sturiale L,Palmigiano A,et al.Glycomics of pediatric and adulthood diseases of the central nervous system[J].J Proteomics,2012,75(17):5123-5139. [23] 郑扬,章殷希,丁美萍.卵巢性脑白质营养不良的研究进展[J].中华神经科杂志,2017,50(5):384-387. [24] Fogli A,Merle C,Roussel V,et al.CSF N-glycan profiles to investigate biomarkers in brain developmental disorders: application to leukodystrophies related to eIF2B mutations[J].PLoS One,2012;7(8):e42688. [25] Sutton-Smith M,Morris HR,Grewal PK,et al.MS screening strategies: Investigating the glycomes of knockout and myodystrophic mice and leukodystrophic human brains[J].Biochem Soc Symp,2002,(69):105-115. [26] Dwyer CA,Esko JD.Glycan susceptibility factors in autism spectrum disorders[J].Mol Aspects Med,2016,51:104-114. [27] Mueller TM,Meador-Woodruff JH.Post-translational protein modifications in schizophrenia[J].NPJ Schizophr.2020,6(1):5. [28] Baysal BE,Willett-Brozick JE,Badner JA,et al.A mannosyltransferase gene at 11q23 is disrupted by a translocation breakpoint that co-segregates with bipolar affective disorder in a small family[J].Neurogenetics,2002,4(1):43-53. [29] Masi A,DeMayo MM,Glozier N,et al.An overview of autism spectrum disorder, heterogeneity and treatment options[J].Neuroscience Bulletin,2017,33(2):183-193. [30] van der Zwaag B,Franke L,Poot M,et al.Gene-network analysis identifies susceptibility genes related to glycobiology in autism[J].PLoS One,2009,4(5):e5324. [31] Yu TW,Chahrour MH,Coulter ME,et al.Using whole-exome sequencing to identify inherited causes of autism[J].Neuron,2013,77(2):259-273. [32] Stalnaker SH,Hashmi S,Lim JM,et al.Site mapping and characterization of O-glycan structures on alpha-dystroglycan isolated from rabbit skeletal muscle[J].J Biol Chem,2010, 285(32):24882-24891. [33] Qin Y,Chen Y,Yang J,et al.Serum glycopattern and Maackia amurensis lectin-Ⅱ binding glycoproteins in autism spectrum disorder[J].Sci Rep,2017,7:46041. [34] Pivac N,Knezevic'A,Gornik O,et al.Human plasma glycome in attention-deficit hyperactivity disorder and autism spectrum disorders[J].Mol Cell Proteomics,2011,10(1):M110.004200. [35] Dennis JW,Lau KS,Demetriou M,et al.Adaptive regulation at the cell surface by N-glycosylation[J].Traffic,2009,10(11):1569-1578. |